Abreos is pioneering personalized dosing for #biologics to ensure that the right patients get the right drug at the right dose.
San Diego, CA
Joined May 2015
- Tweets207
- Following660
- Followers288
- Likes180
Pinned Tweet
At Abreos Biosciences, we want the Right Drug for the Right Patient at the Right Amount youtube.com/watch?v=1xi5Ypqt… #MedTechInnovator
Abreos Biosciences enters research collaboration with the FDA’s Center for Drug Evaluation and Research (CDER) story.cd/AALNHo
Announcing partnership with ResearchDx, a CLIA approved, CAP accredited companion diagnostics organization based in Irvine, CA to help design and develop products using Abreos' patented Veritope technology! story.cd/AAJ3XI
Thank you to @MSNewsToday for sharing @AbreosBio's exciting launch of our FDA-cleared LDT for the drug monitoring of #Tysabri!!
New Post: Test to Monitor Tysabri Levels in RMS Patients, moNATor by Abreos Biosciences, Now Available in US buff.ly/2P7xlao
See what #MultipleSclerosis doctors are saying about #moNATor: “...recent data regarding #Tysabri dosing interval extension and PML risk reduction is a major advance. The moNATor assay provides another tool to the clinician which may help to optimize patient care” -Dr. John Foley
So excited to be announcing the launch of our first commercial product! Available TODAY! Order your Tysabri laboratory diagnostic test at abreos.com story.cd/AAJze6
If you are a #MultipleSclerosis patient on Tysabri, take the guessing game out of dosing regimen with #moNATor, launching NEXT WEEK! Go to abreosbio.com to pre-order your drug monitoring kit now.
The commercial availability of #moNATor is ever so important given recent @BiogenMS announcements showing a significant reduction in #PML risk for patients on extended interval dosing (EID). Follow @AbreosBio for the latest updates on our product launch and #MultipleSclerosis
We are launching a laboratory developed test for precision dose monitoring of Natalizumab (#Tysabri)! Our novel assay addresses the substantial unmet need for physicians to more effectively monitor biologic drug levels in patients with #MultipleSclerosis #PML #PrecisionMedicine
Abreos Biosciences retweeted
Are you at #AAN2018? Stop by and visit #SpringboardAccelerator grad @AbreosBio (Booth #1260)! #MadeInSanDiego #Neurology teapawt.net/AbreosBio/status/98745…
Attending #AAN2018? Come by and visit us at booth #1260! We'll be giving out a sweet surprise to the first visitors... Exhibitor hours start Sunday, April 22nd at 11:30 AM. @AANMember #Neurology
There once was a company in LA
Giving out something sweet during the day
Twas only a few
Come one, come all and view
Booth #1260 today!
@AANMember @TheCravory #AAN2018 #Neurology
Attending #AAN2018? Come by and visit us at booth #1260! We'll be giving out a sweet surprise to the first visitors... Exhibitor hours start Sunday, April 22nd at 11:30 AM. @AANMember #Neurology
Attending AAN? Come by and visit us at booth #1260! We'll be giving out a sweet surprise to the first visitors... Exhibitor hours start Sunday, April 22nd at 11:30 AM.
Abreos Biosciences retweeted
Biocom member @AbreosBio (winner of our 2016 Five in 5 challenge) presents on their mission to become the trusted source for biologic drug monitoring & create value for all healthcare stakeholders by ensuring that patients have the right drug at the right dose #BiocomPartnering
Abreos Biosciences retweeted
Don’t miss our last round of company presentations from @AmarantusBio, Histogen, @AbreosBio, Denovo Biopharma, MDI Therapeutics, and @rapidnovor. The first session starts in 5 minutes! #BiocomPartnering
"...when the extended dosing regimens were applied, with risk reduction for PML as high as 94 percent."
Extending Dosing Intervals Reduces Deadly Side Effect Risk from Popular Multiple Sclerosis Drug #PrecisionMedicine #MultipleSclerosis nyulangone.org/press-release…
Abreos Biosciences retweeted
Congratulations to the @AbreosBio team - Zen is so proud to be working with you to enable dose monitoring of biologics for the masses! @PMWCintl #PrecisionMedicine #PMWC18 teapawt.net/AbreosBio/status/95627…
Proud to announce that Abreos was selected as the winner of the #PMWC18 Silicon Valley Most Promising Company Award! Thank you to all that attended the event, we are excited to bring important #PrecisionMedicine technologies to patients.
Proud to announce that Abreos was selected as the winner of the #PMWC18 Silicon Valley Most Promising Company Award! Thank you to all that attended the event, we are excited to bring important #PrecisionMedicine technologies to patients.
Abreos Biosciences retweeted
3 days to apply! Seeking the best device, diagnostic, or digital companies in the world to compete for $500K+ in cash prizes in the medtech industry's premiere accelerator. Founder friendly. No equity or participation fee. Apply now: medtechinnovator.org/apply
Abreos Biosciences retweeted
Big congrats to @AbreosBio for winning the #PrecisionMedicine #PMWC18 Silicon Valley Most Promising Company Award. @MedTechAwards 2017 finalist doing great things for patients! teapawt.net/PMWCintl/status/956204…
Abreos Biosciences & Immusoft win the #PMWC18 Silicon Valley Most Promising Company Award. Congratulations to both companies! Learn more about @AbreosBio at ow.ly/HP1930hYyOA and @immusoft at ow.ly/frlp30hYyPp #precisionmedicine #startups
